Fritextsökning
Innehållstyper
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Grönt ljus för Hamlet – startar klinisk studie
Fritt fram för klinisk studie med bröstmjölksprotein mot blåscancer.
-
Framtidens laboratorium i fokus på fackmässan Analytica
Messe München laddar för att återigen ta emot världens laboratoriebransch
-
Hitflyttade ska sälja Sverige
Internationella nyckelpersoner hyllar Sverige som life science-nation i slutfasen av EMA-striden.
-
Inga svenska företag i topp 50
Varje år sammanställer Boston Consulting Group en lista över världens 50 mest innovativa företag. Inga svenska företag finns representerade på årets lista som t...
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Tom Britton: ”Nivån för flockimmunitet är lägre än vad vi trott”
Nya matematiska modeller pekar på att flockimmunitetsnivån är kraftigt lägre än vad man tidigare trott, och att immuniteten i dagsläget spelar en större roll, e...
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
”Det börjar dyka upp produkter på marknaden som inte ska vara där”
Aldrig har utvecklingen av diagnostik gått så snabbt som nu och nya självtester för covid-19 dyker upp i snabb takt. Samtidigt slinker självtester som inte leve...
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
Unga forskare prisas
Upptäckt koppling mellan tarmfloran och fetma belönas när pris för unga forskare delas ut i Stockholm.